Odyssey Health, Inc.
For the period ended Jul 31, 2026. Filed Oct 28, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Oct 28, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
| Item 9B. | Other Information |
|---|
During the quarter ended July 31, 2026, no director or officer adopted orterminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408(a) of Regulation S-K.
On October 23, 2026, the Company entered into a Global Amendment with Mast Hill Fund, L.P. amending the Company’s outstanding promissory notes held by Mast Hill. The Global Amendment extended the maturity date of each note to January 31, 2027 and provided one-time waivers of certain events of default, as described in Note 7 to the financial statements included in this Annual Report. The foregoing description is qualified in its entirety by reference to the full text of the Global Amendment, which is filed as Exhibit 10.74 to this Annual Report and incorporated herein by reference.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.